SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MJ who wrote (45)4/17/1997 9:26:00 AM
From: Mark B. Martell, CCM   of 1510
 
This stock still puzzles me. There is a lack of discussion regarding
it, and I'm not sure what to make of that. The company had an announcement
on April 15th regarding Remune, but no discussion insued on this thread.
I'm wondering whether or not this compound will be rushed to market, in that
Gallo's note that chemokines are a key element to fighting aids in an immunization
process.

Anyone with any thoughts on this? The announcement comes out and the stock
has slightly dropped. What are the expectations here?

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext